If you look at the corporate web site for eviCore Healthcare, the company describes itself as follows: … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Treatment | Tagged: classification, experimenta;l, guideline, investigational | 6 Comments »
PI-RADS is an acronym and it stands for “prostate imaging — reporting and data system” but what it really is is a highly structured method for reporting what can be seen on certain types of prostate-specific magnetic resonance imaging (MRI) scan and how to interpret these data. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: classification, grade, PI-RADS, risk, score | 8 Comments »
Traditionally cancers have been classified according to their organ system of origin: prostate cancer, breast cancer, color-rectal cancer, etc. For several years now, it has been evident that this historic classification system needed a major overhaul … and that overhaul is now coming closer. … READ MORE …
Filed under: Diagnosis, Management | Tagged: cancer, classification, type | 1 Comment »
An article by a respected group of researchers at the University of Texas M. D. Anderson Cancer Center in Houston, published in the August issue of Cancer Discovery, proposes a new classification system for progression of prostate cancer over time. This has implications for the appropriate development and use of markers for use in treatment and drug development. … READ MORE …
Filed under: Diagnosis, Drugs in development, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: classification, markers, mechanism, model, progression | 6 Comments »
A group of Japanese researchers has suggested that it may be beneficial to subdivide the D’Amico “high risk” patient group into two subgroups. … READ MORE ..
Filed under: Diagnosis, Management, Risk, Treatment | Tagged: classification, criteria, D'Amico. risk | 1 Comment »
There’s an article in today’s Wall Street Journal that begins, “Scientists may soon be able to answer the agonizing question facing men with prostate cancer.” The agonizing question is whether a specific individual actually needs early and aggressive treatment for his cancer or can simply monitor it for risk of progression. … READ MORE …
Filed under: Diagnosis, Management, Risk | Tagged: classification, genetics, profiling, progression, risk | 3 Comments »
FRET stands for “fluorescence resonance-energy transfer.” It’s a way to assess interactions between individual protein molecules, and allows researchers to find out how many receptors of specific types there are in a specific cancer specimen as well as how active those receptors are. … READ MORE …
Filed under: Diagnosis, Risk, Uncategorized | Tagged: classification, FRET, pathology | Leave a comment »
